Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Infect Dis. 2001 Dec 15;33 Suppl 4:S306-11.

Analysis of studies to evaluate immune response to combination vaccines.

Author information

  • 1Vaccine and Blood Product Evaluation Branch, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Rockville, MD 20852, USA. horne@cber.fda.gov

Abstract

The development and evaluation of new combination vaccines is an important public health endeavor. Trials to evaluate these vaccines are customarily designed and analyzed as noninferiority studies. We explain the concept of noninferiority and highlight important issues that can be challenging in the statistical evaluation of these vaccines. Topics covered include end points, hypotheses, and analyses for comparing geometric mean concentrations (or titers) of antibody and proportion of vaccine recipients responding; covariate adjustment; the problem of multiplicity and its impact on sample size; and choice of a meaningful difference to rule out.

PMID:
11709764
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk